Blood Gas Analyzer Market worth $3.38 billion by 2030
The report "Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030", is valued at an estimated USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030 at a CAGR of 4.6% during the forecast period.
Browse 216 market data Tables and 50 Figures spread through 306 Pages and in-depth TOC on "Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/blood-gas-analyzer-market-242278963.html
The blood gas analyzer market is set to experience robust growth driven by several key factors. Firstly, advances in technology such as multi-parameter analysis, automated calibration, and real-time data integration have improved the accuracy and efficiency of blood gas monitoring, enabling better clinical decision-making. Furthermore, the growing adoption of point-of-care testing in critical care, emergency, and respiratory care settings, expanding healthcare infrastructure, and increasing healthcare spending in developing regions are further propelling market growth.
In 2024, the arterial blood segment held the largest share of the blood gas analyzer market by sample type segment.
The blood gas analyzer market is segmented based on sample type into arterial, venous, and capillary blood. In 2024, the arterial blood segment held the largest share of the market, as it provides the most accurate and reliable measurement of oxygen, carbon dioxide, and pH levels, which are critical for patient assessment. Arterial sampling is widely preferred in hospitals and critical care settings for routine monitoring and clinical decision-making, driving higher demand.
In 2024, the critical care management segment held the largest share of the blood gas analyzer market by application segment.
The blood gas analyzer market is segmented by application into critical care management, respiratory care, emergency care management, and other applications. In 2024, critical care management held the largest share, as patients in intensive care units require frequent monitoring of blood gas levels to manage critical and unstable health conditions. The high frequency of testing in ICUs, where multiple measurements may be performed per patient daily, drives substantial demand for blood gas analyzers in this application area.
North America has the largest regional share in the blood gas analyzer market.
The blood gas analyzer market is divided into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest share, primarily driven by its well-established diagnostics ecosystem, with the US as the primary contributor. This regional dominance is supported by strong healthcare infrastructure, a high prevalence of chronic and acute diseases, and significant investments in advanced diagnostic technologies and innovations.
The major players operating in this market are Danaher Corporation (US), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. (Japan), IDEXX Laboratories, Inc. (US), EDAN Instruments, Inc. (China), and Guangzhou Wondfo Biotech Co., Ltd. (China).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Blood Gas Analyzer Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
